Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1153 | 1022 | 1220 | 1259 | 1495 | 2032 |
Fund Return | 15.32% | 2.24% | 22.01% | 7.98% | 8.38% | 7.35% |
Place in category | 131 | 973 | 255 | 363 | 547 | 171 |
% in Category | 5 | 42 | 11 | 20 | 35 | 13 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GS India Equity Portfolio E Acc | 5.01B | 24.80 | 11.16 | 12.29 | ||
GS Global CORE Equity Portfolio E C | 4.57B | 18.81 | 8.53 | 10.24 | ||
GS Global CORE Equity Portfolio I E | 4.57B | 19.99 | 9.96 | 11.71 | ||
Goldman Sachs Global CORE Equity Pe | 4.57B | 18.07 | 8.02 | 10.20 | ||
LU1357028890 | 3.43B | 16.25 | -4.77 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
European Growth Fund A Acc EUR | 161.29M | 15.19 | 6.23 | 5.66 | ||
European Growth Fund E Acc EUR | 21.19M | 14.50 | 5.44 | 4.87 | ||
European Growth Fund Y Acc EUR | 146.01M | 15.85 | 7.14 | 6.53 | ||
European Growth Fund Y DIST EUR | 66.51M | 15.91 | 7.15 | 6.54 | ||
European Growth Fund A DIST Eue | 6.64B | 15.15 | 6.24 | 5.66 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 5.20 | 807.2 | -1.15% | |
Nestle | CH0038863350 | 3.77 | 85.98 | -0.02% | |
Roche Holding Participation | CH0012032048 | 3.38 | 273.30 | +0.63% | |
Novartis | CH0012005267 | 3.28 | 100.98 | +0.02% | |
SAP | DE0007164600 | 3.23 | 212.850 | +0.59% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review